Status:
RECRUITING
Brain STimulation for ANxiety and Depression in Youth
Lead Sponsor:
University of Calgary
Conditions:
Anxiety Disorders
Depression
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
Detailed Description
Mental health disorders are a leading cause of disability, and approximately 14% of adolescents are diagnosed globally. Within Canada, the prevalence of mental health disorders is increasing, with you...
Eligibility Criteria
Inclusion
- aged between 6 and 18 years old
- diagnosis of anxiety or depression made by a qualified medical professional
- active anxiety and/or depression symptoms
Exclusion
- status epilepticus in past 12-months
- presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study
- hospitalization for suicide attempt within the past 3 months
- TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
- if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety
- unable to understand instructions in English
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06892847
Start Date
July 1 2025
End Date
December 31 2028
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8